Month: December 2015

Momentum Stocks

Bear of the Day: DuPont (DD)

December 3, 2015 0

Agricultural commodity price weakness and a strong dollar have created a very challenging for DuPont, resulting in slashing of estimates by analysts and sending the stock to a Zacks Rank #5 (Strong Sell). About the Company Delaware-based DuPont ( DD ) is a global science and technology company with product offerings in Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials and Safety & Protection. Earlier this year, the company completed the spinoff of its Performance Chemicals segment. […]

Momentum Stocks

Bull of the Day: TAL Education Group (XRS)

December 3, 2015 0

After an excellent quarterly performance, estimates for China’s leading private education provider have been rising, sending the stock back to a Zacks rank #1 (Strong Buy). About the Company TAL Education Group ( XRS ) is a leading K-12 after-school tutoring services provider in China. […]

Mergers & Acquisitions

Brennan Investment Group Acquires Eight Building Industrial Portfolio In Orlando

December 3, 2015 0

Brennan Investment Group Acquires Eight Building Industrial Portfolio In Orlando Transaction is Brennan’s second Orlando portfolio acquisition in 2015 PR Newswire CHICAGO, Dec. 3, 2015 CHICAGO , Dec. 3, 2015 /PRNewswire/ — Brennan Investment Group, LLC, a private real estate investment firm that acquires, develops and operates industrial properties on a national basis, has acquired an eight-building industrial portfolio totaling 254,915 square feet […]

Mergers & Acquisitions

Way To Blue Acquires Digital Agency The Project Factory

December 3, 2015 0

Way To Blue Acquires Digital Agency The Project Factory PR Newswire LONDON, December 3, 2015 LONDON , December 3, 2015 /PRNewswire/ — Way To Blue (WTB), the global communications agency, today announces the acquisition of The Project Factory (TPF), the UK and Australian-based digital creative agency. The all cash deal will bolster Way To Blue’s growing social and digital teams in London and quadruple the size of its Australian footprint. […]

Mergers & Acquisitions

Cytos Biotechnology and Kuros Biosurgery to Combine to Create Kuros Biosciences

December 3, 2015 0

Cytos Biotechnology and Kuros Biosurgery to Combine to Create Kuros Biosciences PR Newswire ZURICH, December 3, 2015 ZURICH , December 3, 2015 /PRNewswire/ — Combined company aims to be a leader in the field of tissue repair and regeneration Late-stage clinical pipeline of novel sealants and orthobiologics products Well financed company following recent Kuros CHF 20 million fund-raising Experienced Board and M anagement T eam Cytos Biotechnology Ltd. (SIX:CYTN) (“Cytos”) and Kuros Biosurgery Holding AG (“Kuros”), today announced their intention to combine their businesses by way of an exchange of Kuros shares for new Cytos shares, subject to shareholder approval and other customary conditions. Cytos is listed on the main segment of the Swiss stock exchange (SIX Swiss Exchange) while Kuros is a privately-held company based in Zurich . […]

Mergers & Acquisitions

Palladium Equity Partners Completes Sale of Taco Bueno

December 2, 2015 0

Palladium Equity Partners Completes Sale of Taco Bueno PR Newswire NEW YORK, Dec. 2, 2015 NEW YORK , Dec. 2, 2015 /PRNewswire/ — Palladium Equity Partners, LLC (along with its affiliates, “Palladium”), a private investment firm with over $2.0 billion in assets under management, today announced that affiliates of the firm have completed the sale of TB Corporation, parent of the Taco Bueno restaurant chain. […]

Stock Analysts

XOMA Inks Agreement with Novo Nordisk for XMetA Program

December 2, 2015 0

XOMA Corporation XOMA announced that it has signed a license agreement with Novo Nordisk A/S NVO , under which Novo Nordisk will acquire the global development and commercialization rights to the company’s XMetA program for the treatment of patient with diabetes. Terms of the Agreement XOMA is entitled to receive an upfront payment of $5 million from Novo Nordisk. In addition, the company is entitled to receive up to $290 million as additional potential development, regulatory and commercial milestones […]

Stock Analysts

NextEra Energy (NEE) Unit to Build Solar Facilities in Hawaii

December 2, 2015 0

NextEra Energy Resources (NEER), a subsidiary of public utility holding company, NextEra Energy, Inc. NEE , has secured a contract to build, own and operate solar power generating systems of approximately 17 megawatts (“MW”) on military installations in Hawaii. In 2011, the Naval Facilities Engineering Command (NAVFAC) Pacific appointed Pacific Energy Solutions, LLC, (PES), an energy development company, to make use of specified sites on military installations in Hawaii to build solar power generating systems and directly sell power to the military […]

Stock Analysts

LTC Properties Buys 2 Skilled Nursing Centers for $23M

December 2, 2015 0

LTC Properties, Inc. LTC disclosed the acquisition of two skilled nursing centers in Texas for $23.0 million. The move would not only help improve the company’s portfolio quality but also enhance its ties with Senior Care Centers, LLC, which is a key and long-standing operating partner of the company […]

Stock Analysts

Unisys (UIS) Spurs Growth Through Portfolio Restructuring

December 2, 2015 0

On Dec 2, Zacks Investment Research updated the research report on information technology firm Unisys Corporation UIS . The information technology industry is presently undergoing a transition phase, forging new disruptive trends in cloud mobility, Big Data, social computing and increasing awareness of cyber security. In order to capitalize on the trends, Unisys is rationalizing its services and solution portfolio by shifting its offerings to cloud-based and software-as-a-service delivery models […]

Stock Analysts

Synthetic (SYN) Unveils Positive Phase IIb Data on SYN-004

December 2, 2015 0

Synthetic Biologics, Inc. SYN announced positive top-line results from the first phase IIa study on SYN-004 for protecting gut microbiome from the unintended effects of certain commonly used intravenous beta-lactam antibiotics for the prevention Clostridium difficile (C. difficile) infection and antibiotic-associated diarrhea. […]

Stock Analysts

Celyad Starts 2nd Cohort of Phase I on NKG2D CAR T-Cell

December 2, 2015 0

Celyad SA CYAD announced that the first patient in the second cohort of its phase I study on NKG2D CAR T-Cell for the treatment of patients with acute myeloid leukemia (AML) and multiple myeloma (MM) has received the infusion. The study will evaluate safety and feasibility of the candidate, with secondary endpoints including clinical activity. The company expects to present complete data from the phase I study in mid-2016 […]